Stueland Katherine sold WGS

March 16, 2026 · Form 4 insider transaction

Stueland Katherine sold 9,229 shares of GeneDx Holdings Corp. at $77.05 per share, a transaction worth $711.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
9,229
Price
$77.05
Total value
$711.1K
RoleOfficer, Director
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after59,219
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.74 to $77.71 per share, inclusive.

View the original Form 4 on SEC EDGAR